Suven Life Sciences Share Price Target For Tomorrow, Next Week & Next Month
Suven Life Sciences Limited | |||
 | Price: ₹207.05 (+1.39%) | ||
| 52 Week Low: ₹102.50 52 Week High: ₹299.99 | |||
| Market Capital: 2,174.19 Crore (Smallcap) | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Suven Life Sciences Stock Comparison: Suven Life Sciences vs IOL Chemicals and Pharmaceuticals Limited | Suven Life Sciences vs Hester Biosciences | Suven Life Sciences vs Themis Medicare | Suven Life Sciences vs TTK Healthcare | Suven Life Sciences vs Tarsons Products | Suven Life Sciences vs Sigachi Industries | |||
Share Price HistorySUVEN FinancialsTomorrow TargetYearly TargetsDividend HistoryBonus HistorySplit History
Show Table of Contents
Suven Life Sciences Recent Performance
Over the past 469 trading days, the value of Suven Life Sciences's stock has gained ₹124.15 (+149.76%). On 07 Nov 2023, one share was worth ₹82.90 and by 01 Oct 2025, the value jumped to ₹207.05. During this period it created a highest high of ₹299.99 and lowest low of ₹74.50.
Suven Life Sciences Share Price Target - Tomorrow
| Level | Value | Analysis |
|---|---|---|
| Tomorrow Target 3 | 237 (+14.46%) | Price Action: 21 Aug 2025 High |
| Tomorrow Target 2 | 234.45 (+13.23%) | Price Action: 23 Sep 2025 High |
| Tomorrow Target 1 | 232 (+12.05%) | Price Action: 05 Jun 2025 Low |
| Current Price | 207.05 | Suven Life Sciences's share price as of 01 Oct 2025 |
| Stop Loss 1 | 182.29 (-11.96%) | Technical Indicator: MA200 |
| Stop Loss 2 | 178.63 (-13.73%) | Fibonacci Retracement Level 78.60% |
| Stop Loss 3 | 174.9 (-15.53%) | Price Action: 13 May 2025 High |
Summary
01 Oct 2025: Suven Life Sciences finished the day at ₹207.05, gaining ₹2.84 (+1.39%) in 1 day.
Our analysis for tomorrow predicts a potential movement of -15.53% to 14.47% with:
- Target prices: ₹232 to ₹237
- Support levels: ₹182.29 to ₹174.9
- Recent high: ₹209.40
- Recent low: ₹202.06
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Suven Life Sciences Share Price Target - Next Week
| Level | Value | Analysis |
|---|---|---|
| Next Week Target 3 | 218 (+5.28%) | Price Action: 19 May 2025 High |
| Next Week Target 2 | 215.5 (+4.08%) | Price Action: 19 Sep 2025 Low |
| Next Week Target 1 | 213.32 (+3.02%) | Price Action: 01 Sep 2025 High |
| Current Price | 207.05 | Suven Life Sciences's share price as of 01 Oct 2025 |
| Stop Loss 1 | 204.6 (-1.19%) | Price Action: 02 Sep 2025 Low |
| Stop Loss 2 | 202.06 (-2.42%) | Price Action: Oct 2025 Low |
| Stop Loss 3 | 200 (-3.41%) | Price Action: Sep 2025 Low |
Weekly Target Summary
For next week, our analysis suggests a potential movement range of -3.40% to 5.29% with:
- Upper targets: ₹213.32 to ₹218
- Support levels: ₹204.6 to ₹200
Suven Life Sciences Share Price Target - Next Month
| Level | Value | Analysis |
|---|---|---|
| Next Month Target 3 | 242 (+16.87%) | Price Action: 18 Jun 2025 High |
| Next Month Target 2 | 239.54 (+15.69%) | Price Action: 04 Jun 2025 High |
| Next Month Target 1 | 236.5 (+14.22%) | Price Action: 25 Aug 2025 High |
| Current Price | 207.05 | Suven Life Sciences's share price as of 01 Oct 2025 |
| Stop Loss 1 | 198.54 (-4.12%) | Price Action: 15 May 2025 High |
| Stop Loss 2 | 196.55 (-5.08%) | Price Action: Chart |
| Stop Loss 3 | 190.58 (-7.96%) | Price Action: 16 May 2025 High |
Monthly Target Summary
Looking ahead to next month, technical analysis indicates:
- Potential price movement: -7.95% to 16.88% with:
- Target range: ₹236.5 to ₹242
- Support levels: ₹198.54 to ₹190.58
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
